Bioarctic AB

Bioarctic AB is an SME in Stockholm, Sweden that has taken part in 6 EU-funded projects since 2015, receiving €985k in EU funding and leading 2 as coordinator.

EU funding received€985k
EU projects6
As coordinator2
Running now3
First EU project2015
Latest project2026
CountrySweden
EU registration (PIC)973842268
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Bioarctic AB's own share of each project, not the project's full budget.

  • Horizon 2020€985k · 3 projects
  • Horizon Europe€0 · 3 projects

Projects

6 EU-funded projects, newest first. Bioarctic AB led 2 of them as coordinator. Each links to the official record.

  • LIPAGGAssociated partner

    From biophysical chemistry to cell biology: Deciphering the role of lipids in the toxicity and spreading of protein aggregation

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • NOVELAssociated partner

    Novel brain health solutions across four focus areas: Prevention and care, Methods and data, Innovation and society, and Ethics and well-being

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • PROMINENTPartner

    PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • PET-AlphaSyPartner

    PET Imaging of Alpha-Synuclein Fibril Formation

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €282ktheir share
  • Biomarkers for PDCoordinator

    Validation of diagnostic and prognostic biomarkers for Parkinson disease

    Horizon 2020 · 2015–2016 · Project on CORDIS ↗

    €50ktheir share
  • SC0806Coordinator

    Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €653ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • cell biology
  • dementia
  • diabetes
  • diagnostic technologies
  • drug discovery
  • implants
  • lipids
  • mortality
  • neurobiology
  • nuclear medicine
  • parkinson
  • pathology
  • pathophysiology
  • personalized medicine

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime